
Catherine Ho
Examiner (ID: 13990)
| Most Active Art Unit | 2924 |
| Art Unit(s) | 2953, 2924 |
| Total Applications | 1329 |
| Issued Applications | 1227 |
| Pending Applications | 20 |
| Abandoned Applications | 93 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20592468
[patent_doc_number] => 12576164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins
[patent_app_type] => utility
[patent_app_number] => 18/424207
[patent_app_country] => US
[patent_app_date] => 2024-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 42052
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 334
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424207
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/424207 | Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins | Jan 25, 2024 | Issued |
Array
(
[id] => 19431101
[patent_doc_number] => 20240299599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/515076
[patent_app_country] => US
[patent_app_date] => 2023-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18515076
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/515076 | DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | Nov 19, 2023 | Pending |
Array
(
[id] => 19114020
[patent_doc_number] => 20240125770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => CELL ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 18/243756
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18243756
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/243756 | CELL ANALYSIS | Sep 7, 2023 | Pending |
Array
(
[id] => 20341944
[patent_doc_number] => 12465660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Compositions and methods for cancer imaging and radiotherapy
[patent_app_type] => utility
[patent_app_number] => 18/360859
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 9979
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18360859
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/360859 | Compositions and methods for cancer imaging and radiotherapy | Jul 27, 2023 | Issued |
Array
(
[id] => 19002065
[patent_doc_number] => 20240066136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => MODIFIED PROTEINS AND PROTEIN DEGRADERS
[patent_app_type] => utility
[patent_app_number] => 18/361422
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361422
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361422 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | Jul 27, 2023 | Pending |
Array
(
[id] => 19125845
[patent_doc_number] => 20240131198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => RATIOMETRIC BIOSENSOR TATTOOS AND USE THEREOF FOR REAL TIME MEASUREMENTS
[patent_app_type] => utility
[patent_app_number] => 18/225564
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/225564 | RATIOMETRIC BIOSENSOR TATTOOS AND USE THEREOF FOR REAL TIME MEASUREMENTS | Jul 23, 2023 | Pending |
Array
(
[id] => 19065774
[patent_doc_number] => 20240100200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => COMPOSITIONS COMPRISING ASCORBIC ACID AND AN IMAGING AGENT AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/357073
[patent_app_country] => US
[patent_app_date] => 2023-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357073
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/357073 | COMPOSITIONS COMPRISING ASCORBIC ACID AND AN IMAGING AGENT AND RELATED METHODS | Jul 20, 2023 | Abandoned |
Array
(
[id] => 18769499
[patent_doc_number] => 20230364269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => TOPICAL APPLICATION OF NERVE LABELING DYES FOR IMAGE-GUIDED SURGERY
[patent_app_type] => utility
[patent_app_number] => 18/350268
[patent_app_country] => US
[patent_app_date] => 2023-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6178
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18350268
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/350268 | TOPICAL APPLICATION OF NERVE LABELING DYES FOR IMAGE-GUIDED SURGERY | Jul 10, 2023 | Pending |
Array
(
[id] => 18953741
[patent_doc_number] => 20240042068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/329245
[patent_app_country] => US
[patent_app_date] => 2023-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18329245
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/329245 | CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF | Jun 4, 2023 | Pending |
Array
(
[id] => 18673169
[patent_doc_number] => 20230310662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => METHODS FOR DIAGNOSING AND MONITORING EOSINOPHILIC ESOPHAGITIS
[patent_app_type] => utility
[patent_app_number] => 18/322854
[patent_app_country] => US
[patent_app_date] => 2023-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18322854
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/322854 | METHODS FOR DIAGNOSING AND MONITORING EOSINOPHILIC ESOPHAGITIS | May 23, 2023 | Pending |
Array
(
[id] => 18752536
[patent_doc_number] => 20230355814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => BINDING PROTEIN TARGETING HER2, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/297032
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/297032 | BINDING PROTEIN TARGETING HER2, PREPARATION METHOD AND USE THEREOF | Apr 6, 2023 | Pending |
Array
(
[id] => 19354029
[patent_doc_number] => 12054458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/186043
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 9362
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18186043
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/186043 | None | Mar 16, 2023 | Issued |
Array
(
[id] => 20770261
[patent_doc_number] => 12653913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-16
[patent_title] => HER2 binders
[patent_app_type] => utility
[patent_app_number] => 18/119070
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 7024
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119070
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/119070 | HER2 binders | Mar 7, 2023 | Issued |
Array
(
[id] => 20686630
[patent_doc_number] => 12616759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-05
[patent_title] => Uses of labeled HSP90 inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/104037
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 119
[patent_no_of_words] => 61666
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104037
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/104037 | Uses of labeled HSP90 inhibitors | Jan 30, 2023 | Issued |
Array
(
[id] => 18707689
[patent_doc_number] => 20230330271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/086378
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086378
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086378 | THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME | Dec 20, 2022 | Pending |
Array
(
[id] => 18483638
[patent_doc_number] => 20230210939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/064677
[patent_app_country] => US
[patent_app_date] => 2022-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18064677
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/064677 | CYCLIC PEPTIDE COMPOUNDS AND METHODS OF USE | Dec 11, 2022 | Pending |
Array
(
[id] => 18298292
[patent_doc_number] => 20230107978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => High Specific Activity Preparation of F-18 Tetrafluoroborate
[patent_app_type] => utility
[patent_app_number] => 18/070175
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070175
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070175 | High Specific Activity Preparation of F-18 Tetrafluoroborate | Nov 27, 2022 | Abandoned |
Array
(
[id] => 20163931
[patent_doc_number] => 20250255977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/706375
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18706375
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/706375 | EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF | Nov 7, 2022 | Pending |
Array
(
[id] => 20329706
[patent_doc_number] => 12459972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Protease-activated contrast agents for in vivo imaging
[patent_app_type] => utility
[patent_app_number] => 18/053682
[patent_app_country] => US
[patent_app_date] => 2022-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 22
[patent_no_of_words] => 11402
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053682
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053682 | Protease-activated contrast agents for in vivo imaging | Nov 7, 2022 | Issued |
Array
(
[id] => 18596103
[patent_doc_number] => 20230270894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/049609
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049609
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049609 | RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING | Oct 24, 2022 | Pending |